Abstract
The efficacy and safety of bioactive compounds depend on a few known and unknown parameters. What is a physiologic dose and how can that dose be defined in cases of bioactive compounds with a poor knowledge of supply and distribution? What safety sets are needed? How can individual aspects such as polymorphisms or differences in absorption be considered? A group of experts tried to answer these and related questions during the 23rd Hohenheim Consensus Meeting at the University of Hohenheim in Stuttgart.
Original language | English |
---|---|
Pages (from-to) | 1206-1211 |
Number of pages | 6 |
Journal | Nutrition |
Volume | 25 |
Issue number | 11-12 |
DOIs | |
Publication status | Published - Nov 2009 |
Keywords
- Biological Markers
- Biological Products
- Dietary Supplements
- Drug Dosage Calculations
- Humans
- Intestinal Absorption
- Polymorphism, Genetic